Octave Intelligence plc has acquired Cerebre, a U.S.-based software firm that creates connected plant models by integrating engineering schematics and plant data. This acquisition aims to strengthen Octave's industrial AI capabilities, especially for brownfield facilities where data is often fragmented. Cerebre's technology allows real-time, unified plant models that improve operational insights and decision-making for major energy companies. The combined solutions will be integrated into Octave's platform, targeting accelerated growth and expanded AI applications in industrial operations.
Octave's acquisition of Cerebre provides context for technology sector activity on Pluang. For readers following Technology-sector US stocks, here is Pluang's market snapshot as of Nov 12, 2026 04:21 WIB: out of 150 priced stocks, 122 rose and 27 fell today. Notable movers include CORZ at USD 14.55 with a 1-day change of +10.81%, SMCI at USD 30.68 with +10.40%, and STX at USD 552.76 with +10.19%. Typical hold times range from 22 to 44 days, with varied Pluang order activity percentages.
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
Vylor, Inc. announced its Q3 2026 financial results showing a slight decline in net sales and increased losses compared to last year, mainly due to volume decreases from weather and market shifts. Despite this, the company saw strong demand for its h...
Castle Biosciences, a diagnostics company specializing in tests for dermatologic and gastroenterological diseases, announced its executive management will present a company overview at the Piper Sandler 38th Annual Healthcare Conference on December 2...
Cardinal Health's Board of Directors has approved a quarterly dividend of $0.5158 per share, to be paid on January 15, 2027. This dividend will be distributed from the company's capital surplus to shareholders recorded by January 4, 2027. Cardinal He...
